Bristol Myers Squibb (BMY) EBITDA Margin (QoQ) (2009 - 2026)

Bristol Myers Squibb (BMY) EBITDA Margin (QoQ) (2009 - 2026) Analysis & Trends

Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Gsk 92,134,969.93 Bn 92,134,964.97 Bn 7.76 Bn
2 Eli Lilly 1,027.45 Bn 1,022.17 Bn 16.22 Bn
3 Johnson & Johnson 559.08 Bn 537.03 Bn 15.96 Bn
4 AbbVie 394.75 Bn 385.40 Bn 10.78 Bn
5 Merck 295.12 Bn 289.47 Bn 12.09 Bn
6 Amgen 186.65 Bn 174.61 Bn 5.87 Bn
7 Gilead Sciences 159.22 Bn 151.50 Bn 5.52 Bn
8 Pfizer 146.00 Bn 133.23 Bn -1.21 Bn
9 Bristol Myers Squibb 113.22 Bn 102.77 Bn 8.07 Bn
10 Novartis Ag 108.02 Bn 107.33 Bn -

Historic Data

Download Data
DateValue
Mar 31, 2026 1,605.00
Dec 31, 2025 -975.00
Sep 30, 2025 872.00
Jun 30, 2025 -1,065.00
Mar 31, 2025 1,783.00
Dec 31, 2024 -764.00
Sep 30, 2024 -323.00
Jun 30, 2024 11,247.00
Mar 31, 2024 -11,224.00
Dec 31, 2023 -542.00
Sep 30, 2023 21.00
Jun 30, 2023 -89.00
Mar 31, 2023 532.00
Dec 31, 2022 -179.00
Sep 30, 2022 171.00
Jun 30, 2022 264.00
Mar 31, 2022 -979.00
Dec 31, 2021 698.00
Sep 30, 2021 487.00
Jun 30, 2021 -1,168.00